Abarelix

Category: Cancer



Abarelix Overview

Abarelix, sold under the brand name Plenaxis, is an injectable gonadotropin-releasing hormone antagonist (GnRH antagonist) which is marketed in Germany and the Netherlands. It is primarily used in oncology to reduce the amount of testosterone made in patients with advanced symptomatic prostate cancer for which no other treatment options are available.[2][3] It was originally marketed by Praecis Pharmaceuticals as Plenaxis,[2] and is now marketed...

Read more Abarelix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abarelix

Recent Abarelix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abarelix
  • Injection: 100mg/vial, 50mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Abarelix or a similar ingredient: (1 result)